BlackRock Health Sciences Trust discloses director Mahoney

BlackRock Health Sciences Trust (BME) filed an initial statement of beneficial ownership for Francis C. Mahoney, who is identified as a director of the trust.

Available on EDGAR 09/17/2026 - 05:04 PM EDT Accepted by SEC EDGAR 09/17/2026 - 05:03 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

BlackRock Health Sciences Trust (BME) filed an initial statement of beneficial ownership for Francis C. Mahoney, who is identified as a director of the trust. The filing does not report any transactions or derivative positions and includes no holding entries at this time.

Key Figures

Buy transactions reported: 0 transactions Sell transactions reported: 0 transactions Holding entries reported: 0 entries

3 metrics

Buy transactions reported 0 transactions Initial insider statement for director Francis C. Mahoney

Sell transactions reported 0 transactions Initial insider statement for director Francis C. Mahoney

Holding entries reported 0 entries No non-derivative or derivative holdings listed in the Form 3

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the new Form 3 filing mean for BlackRock Health Sciences Trust (BME)?

The Form 3 reports that Francis C. Mahoney is a director of BlackRock Health Sciences Trust. It is an initial statement of insider status and shows no reported transactions or holdings in this filing.

Does the Form 3 show any share purchases or sales for BME by Francis C. Mahoney?

No. The transaction summary shows 0 buy transactions, 0 sell transactions, and no other types of transactions reported for Francis C. Mahoney in this Form 3.

Are any existing share holdings for BME disclosed for Francis C. Mahoney in this Form 3?

No. The data indicate 0 holding entries and an empty derivative securities summary, so no specific BME share or option positions are disclosed in this filing.

Is there any Rule 10b5-1 trading plan disclosed in this BME Form 3?

No. The document-level indicator for a Rule 10b5-1 plan is null, and there are no transactions or footnotes describing any trading plan in this Form 3.

What insider role does Francis C. Mahoney have at BlackRock Health Sciences Trust (BME)?

Francis C. Mahoney is reported as a director of BlackRock Health Sciences Trust, with no officer title or ten percent owner status indicated in the Form 3 data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mahoney Francis C.

(Last) (First) (Middle)

50 HUDSON YARDS

(Street)

NEW YORK NEW YORK 10001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/08/2026

3. Issuer Name and Ticker or Trading Symbol
BlackRock Health Sciences Trust [ BME ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Gladys Chang as Attorney-in-Fact	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)